Most sold healthcare stocks in Q1 2014
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2014, measured as net reductions in reported share positions from Q4 2013 into Q1 2014. Notable reductions at the top of this list include PFIZER INC (PFE), MERCK & CO. INC. (MRK), REVVITY INC (RVTY), DANAHER CORP (DHR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PFE | PFIZER INC | -10,153,648 | -$196.06M | 0 | 6 | 5 | 1 | 13 |
| MRK | MERCK & CO. INC. | -8,555,641 | -$135.50M | 1 | 2 | 8 | 1 | 14 |
| RVTY | REVVITY INC | -5,331,114 | -$218.57M | 0 | 1 | 0 | 3 | 1 |
| DHR | DANAHER CORP | -4,816,039 | -$375.55M | 1 | 2 | 1 | 2 | 4 |
| BSX | BOSTON SCIENTIFIC CORP | -3,579,215 | $27.24M | 0 | 0 | 3 | 0 | 3 |
| ZTS | ZOETIS INC | -3,551,835 | -$131.50M | 0 | 1 | 2 | 1 | 3 |
| ABT | ABBOTT LABORATORIES | -3,423,293 | -$127.13M | 0 | 6 | 3 | 2 | 11 |
| A | AGILENT TECHNOLOGIES INC | -3,038,886 | -$178.53M | 0 | 1 | 2 | 2 | 3 |
| JNJ | JOHNSON & JOHNSON | -2,700,264 | -$88.40M | 0 | 10 | 3 | 3 | 20 |
| HCA | HCA HEALTHCARE INC | -2,654,617 | -$126.65M | 0 | 0 | 0 | 1 | 0 |
| MASI | MASIMO CORP | -2,153,144 | -$62.94M | 0 | 0 | 0 | 1 | 0 |
| LLY | ELI LILLY & CO | -1,831,623 | -$45.84M | 0 | 0 | 5 | 0 | 6 |
| GILD | GILEAD SCIENCES INC | -1,779,001 | -$156.82M | 1 | 6 | 1 | 3 | 9 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -1,734,960 | -$116.98M | 0 | 1 | 2 | 0 | 3 |
| TMO | THERMO FISHER SCIENTIFIC INC | -1,684,820 | -$36.22M | 1 | 0 | 7 | 0 | 9 |
| MCK | MCKESSON CORP | -1,306,974 | -$210.95M | 0 | 0 | 0 | 2 | 0 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,286,400 | -$66.44M | 0 | 0 | 1 | 0 | 3 |
| WAT | WATERS CORP | -1,170,643 | -$99.63M | 0 | 1 | 2 | 0 | 3 |
| CORT | CORCEPT THERAPEUTICS INC | -991,978 | -$3.19M | 0 | 0 | 0 | 1 | 0 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | -897,224 | -$5.50M | 0 | 1 | 0 | 1 | 1 |
| AMGN | AMGEN INC | -798,467 | -$86.01M | 0 | 2 | 2 | 2 | 6 |
| HUM | HUMANA INC | -780,193 | -$79.14M | 1 | 0 | 0 | 1 | 1 |
| EXEL | EXELIXIS INC | -773,300 | -$5.78M | 0 | 0 | 1 | 0 | 1 |
| DVA | DAVITA INC | -641,289 | $216.32M | 0 | 3 | 3 | 0 | 6 |
| SYK | STRYKER CORP | -614,565 | $42.55M | 0 | 1 | 3 | 1 | 4 |
| RMD | RESMED INC | -605,000 | -$30.96M | 0 | 0 | 1 | 0 | 3 |
| CRL | CHARLES RIVER LABORATORIES | -573,246 | -$9.29M | 0 | 1 | 2 | 0 | 3 |
| NVS | NOVARTIS AG-SPONSORED ADR | -454,902 | $200.10M | 0 | 4 | 4 | 0 | 9 |
| ALKS | ALKERMES PLC | -452,276 | -$18.21M | 0 | 0 | 1 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | -447,550 | -$4.54M | 0 | 0 | 1 | 0 | 1 |
| MOH | MOLINA HEALTHCARE INC | -415,282 | -$14.25M | 0 | 0 | 1 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | -404,413 | -$7.44M | 0 | 0 | 1 | 1 | 1 |
| CHE | CHEMED CORP | -387,767 | -$13.39M | 2 | 0 | 2 | 0 | 4 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | -384,800 | -$15.11M | 0 | 0 | 0 | 1 | 0 |
| CAH | CARDINAL HEALTH INC | -371,597 | -$19.05M | 0 | 1 | 2 | 1 | 4 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -337,575 | -$21.73M | 0 | 1 | 0 | 1 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | -278,401 | -$689.00K | 0 | 0 | 1 | 0 | 1 |
| BIIB | BIOGEN INC | -241,047 | -$56.91M | 1 | 1 | 0 | 2 | 3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -215,266 | -$15.28M | 1 | 0 | 0 | 1 | 1 |
| DGX | QUEST DIAGNOSTICS INC | -206,804 | -$5.04M | 0 | 3 | 1 | 0 | 4 |
| ARAY | ACCURAY INC | -199,883 | -$1.52M | 0 | 0 | 1 | 0 | 1 |
| ISRG | INTUITIVE SURGICAL INC | -184,362 | -$55.65M | 0 | 0 | 3 | 0 | 3 |
| DXCM | DEXCOM INC | -176,700 | -$3.99M | 0 | 0 | 1 | 0 | 1 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -168,291 | -$11.37M | 1 | 0 | 1 | 0 | 2 |
| GMED | GLOBUS MEDICAL INC - A | -153,882 | -$1.61M | 0 | 0 | 2 | 0 | 2 |
| FONR | FONAR CORP | -148,800 | -$4.53M | 0 | 0 | 1 | 0 | 1 |
| CYTK | CYTOKINETICS INC | -147,200 | -$392.00K | 0 | 0 | 1 | 0 | 1 |
| ANGO | ANGIODYNAMICS INC | -118,500 | -$2.13M | 0 | 0 | 1 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | -100,350 | -$877.00K | 0 | 0 | 0 | 1 | 0 |
| RGEN | REPLIGEN CORP | -97,407 | -$1.69M | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q1 2014
What are the most sold Healthcare stocks in Q1 2014?
The most sold healthcare stocks in Q1 2014 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2013, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2014?
Among filers in this sector, net reductions were largest in companies such as PFIZER INC (PFE), MERCK & CO. INC. (MRK), REVVITY INC (RVTY), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2013).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.